Bioterrorism-related anthrax: International response by the Centers for Disease Control and Prevention

被引:9
|
作者
Polyak, CS
Macy, JT
Irizarry-De la Cruz, M
Lai, JE
McAuliffe, JF
Popovic, T
Pillai, SP
Mintz, ED
机构
[1] Ctr Dis Control & Prevent, Foodborne & Diarrheal Dis Branch, Atlanta, GA 30333 USA
[2] Dept Hlth, Bur Labs, Miami, FL USA
关键词
D O I
10.3201/eid0810.020345
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
After reports of the intentional release of Bacillus anthracis in the United States, epidemiologists, laboratorians, and clinicians around the world were called upon to respond to widespread political and public concerns. To respond to inquiries from other countries regarding anthrax and bioterrorism, the Centers for Disease Control and Prevention established an international team in its Emergency Operations Center. From October 12, 2001, to January 2, 2002, this team received 130 requests from 70 countries and 2 territories. Requests originated from ministries of health, international organizations, and physicians and included subjects ranging from laboratory procedures and clinical evaluations to assessments of environmental and occupational health risks. The information and technical support provided by the international team helped allay fears, prevent unnecessary antibiotic treatment, and enhance laboratory-based surveillance for bioterrorism events worldwide.
引用
收藏
页码:1056 / 1059
页数:4
相关论文
共 50 条
  • [21] First case of bioterrorism-related inhalational anthrax, Florida, 2001: North Carolina investigation
    Maillard, JM
    Fischer, M
    McKee, KT
    Turner, LF
    Cline, JS
    EMERGING INFECTIOUS DISEASES, 2002, 8 (10) : 1035 - 1038
  • [22] Laboratory aspects of bioterrorism-related anthrax - from identification to molecular subtyping to microbial forensics
    Popovic, T
    Glass, M
    CROATIAN MEDICAL JOURNAL, 2003, 44 (03) : 336 - 341
  • [23] Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthrax
    Quinn, CP
    Dull, PM
    Semenova, V
    Li, H
    Crotty, S
    Taylor, TH
    Steward-Clark, E
    Stamey, KL
    Schmidt, DS
    Stinson, KW
    Freeman, AE
    Elie, CM
    Martin, SK
    Greene, C
    Aubert, RD
    Glidewell, J
    Perkins, BA
    Ahmed, R
    Stephens, DS
    JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (07): : 1228 - 1236
  • [24] Systematic Review of Hospital Treatment Outcomes for Naturally Acquired and Bioterrorism-Related Anthrax, 1880-2018
    Person, Marissa K.
    Cook, Rachel
    Bradley, John S.
    Hupert, Nathaniel
    Bower, William A.
    Hendricks, Katherine
    CLINICAL INFECTIOUS DISEASES, 2022, 75 : S392 - S401
  • [25] Patients' request for and emergency physicians' prescription of antimicrobial prophylaxis for anthrax during the 2001 bioterrorism-related outbreak
    Nkuchia M M'ikanatha
    Kathleen G Julian
    Allen R Kunselman
    Robert C Aber
    James T Rankin
    Ebbing Lautenbach
    BMC Public Health, 5
  • [26] Patients' request for and emergency physicians' prescription of antimicrobial prophylaxis for anthrax during the 2001 bioterrorism-related outbreak
    M'ikanatha, NM
    Julian, KG
    Kunselman, AR
    Aber, RC
    Rankin, JT
    Lautenbach, E
    BMC PUBLIC HEALTH, 2005, 5 (1)
  • [27] First case of bioterrorism-related inhalational anthrax in the United States, Palm Beach County, Florida, 2001
    Traeger, MS
    Wiersma, ST
    Rosenstein, NE
    Malecki, JM
    Shepard, CW
    Raghunathan, PL
    Pillai, SP
    Popovic, T
    Quinn, CP
    Meyer, RF
    Zaki, SR
    Kumar, S
    Bruce, SM
    Sejvar, JJ
    Dull, PM
    Tierney, BC
    Jones, JD
    Perkins, BA
    EMERGING INFECTIOUS DISEASES, 2002, 8 (10) : 1029 - 1034
  • [28] The centers for disease control bioterrorism investigation
    Yeskey, K
    BIOLOGICAL THREATS AND TERRORISM, WORKSHOP SUMMARY: ASSESSING THE SCIENCE AND RESPONSE CAPABILITIES, 2002, : 154 - 155